Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Corbeau, P."" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up.
Autorzy:
Vassallo M; Department of Internal Medicine/Infectious Diseases, Cannes General Hospital, 06400 Cannes, France.; Unité de Recherche Clinique Cote d'Azur (UR2CA), URRIS, Centre Hospitalier Universitaire Pasteur 2, 06300 Nice, France.
Durant J; Department of Infectious Diseases, University Côte d'Azur, 06108 Nice, France.
Fabre R; Department of Public Health, L'Archet Hospital, University of Nice, 06107 Nice, France.; CoBteK (Cognition-Behaviour-Technology) Lab, FRIS-University Côte d'Azur, 06108 Nice, France.
Lotte L; Multipurpose Laboratory, Cannes General Hospital, 06400 Cannes, France.
Sindt A; Multipurpose Laboratory, Cannes General Hospital, 06400 Cannes, France.
Puchois A; Multipurpose Laboratory, Cannes General Hospital, 06400 Cannes, France.
De Monte A; Laboratory of Virology, Nice University Hospital, University Côte d'Azur, 06108 Nice, France.
Cezar R; Laboratory of Immunology, Nimes University Hospital, 30029 Nimes, France.
Corbeau P; Laboratory of Immunology, Nimes University Hospital, 30029 Nimes, France.
Pradier C; Department of Public Health, L'Archet Hospital, University of Nice, 06107 Nice, France.; CoBteK (Cognition-Behaviour-Technology) Lab, FRIS-University Côte d'Azur, 06108 Nice, France.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Apr 28; Vol. 14 (5). Date of Electronic Publication: 2022 Apr 28.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Biomarkers ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prospective Studies ; Viral Load ; Viremia
Czasopismo naukowe
Tytuł:
Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?
Autorzy:
Moreno S; Department of Infectious Diseases, University Hospital Ramón y Cajal, Alcalá University, IRYCIS, Madrid, Spain.
Perno CF; Department of Laboratory Medicine, ASST Niguarda Hospital, University of Milan, Milan, Italy.
Mallon PW; HIV Molecular Research Group, School of Medicine, University College Dublin, Dublin, Ireland.
Behrens G; Department for Rheumatology and Clinical Immunology, Hannover Medical School, Hannover, Germany.
Corbeau P; Institute for Human Genetics, CNRS-Montpellier University UMR9002, Montpellier, France.; Immunology Department, University Hospital, Nîmes, France.
Routy JP; Division of Hematology and Chronic Viral Infection Service, McGill University Health Centre, Montréal, QC, Canada.
Darcis G; Department of Infectious Diseases, Liege University Hospital, University of Liege, Liège, Belgium.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2019 Apr; Vol. 20 Suppl 4, pp. 2-12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug Substitution*
Anti-Retroviral Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
CD4 Lymphocyte Count ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Humans ; Sustained Virologic Response
Czasopismo naukowe
Tytuł:
Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.
Autorzy:
Younas M; Institute of Human Genetics, CNRS UPR1142, Montpellier Cedex 5, France.
Psomas C; Infectious Diseases Department, University Hospital, Montpellier Cedex 5, France.; UMI 233, IRD-Montpellier University, Montpellier Cedex 5, France.
Reynes J; Infectious Diseases Department, University Hospital, Montpellier Cedex 5, France.; UMI 233, IRD-Montpellier University, Montpellier Cedex 5, France.; Montpellier University, Montpellier, France.
Corbeau P; Institute of Human Genetics, CNRS UPR1142, Montpellier Cedex 5, France.; Montpellier University, Montpellier, France.; Immunology Department, University Hospital, Nîmes Cedex, France.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2016 Feb; Vol. 17 (2), pp. 89-105. Date of Electronic Publication: 2015 Oct 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD4-Positive T-Lymphocytes/*metabolism
CD8-Positive T-Lymphocytes/*metabolism
HIV Infections/*immunology
HIV-1/*immunology
Inflammation/*immunology
Lymphocyte Activation/*immunology
Antiretroviral Therapy, Highly Active ; Biomarkers/metabolism ; CD4-CD8 Ratio ; Disease Progression ; HIV Infections/drug therapy ; HIV Infections/physiopathology ; Humans ; Inflammation/physiopathology ; Intestinal Mucosa/immunology ; Phenotype ; Viral Load
Czasopismo naukowe
Tytuł:
The intensity of immune activation is linked to the level of CCR5 expression in human immunodeficiency virus type 1-infected persons.
Autorzy:
Portales P; Département d'Immunologie, CHU de Montpellier, Université Montpellier 1, Montpellier, France.
Psomas KC
Tuaillon E
Mura T
Vendrell JP
Eliaou JF
Reynes J
Corbeau P
Pokaż więcej
Źródło:
Immunology [Immunology] 2012 Sep; Vol. 137 (1), pp. 89-97.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/immunology
HIV-1*/pathogenicity
Lymphocyte Activation*
ADP-ribosyl Cyclase 1/*biosynthesis
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
HIV Infections/*immunology
Receptors, CCR5/*immunology
Receptors, CCR5/*metabolism
Antiretroviral Therapy, Highly Active ; CD4-Positive T-Lymphocytes/cytology ; CD4-Positive T-Lymphocytes/virology ; CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/virology ; HIV Infections/drug therapy ; HIV Infections/virology ; Humans ; Receptors, Death Domain/metabolism ; Viral Load
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies